Clinical Trial: Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With ADH1
Study Status: Completed
Recruit Status: RECRUITING
Condition: Autosomal Dominant Hypocalcemia (ADH)
Study Type: INTERVENTIONAL
Official Title: CALIBRATE: A Phase 3, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Encaleret Compared to Standard of Care in Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Brief Summary:
The primary purpose of the study is to understand the effectiveness, safety, and tolerability of encaleret when compared to standard of care (SoC) treatment in participants with ADH1.
Read more